Source: DGNews  |  Posted 8 years ago

TORONTO, ON -- September 9, 2003 -- Based on landmark clinical trial results, today's Health Canada approval could mean new hope for Canadians at high risk of developing multiple sclerosis.

Following closely on the heels of the FDA, Canadian authorities have now approved Biogen, Inc.'s Avonex